South Dakota · 2026
HB 1099
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Bill record: Open States bulk CSV (bills/votes) CC0-1.0
Summary AI-generated
South Dakota House Bill 1099 proposes to reschedule the pharmaceutical composition of crystalline polymorph psilocybin found in a drug product approved by the Food and Drug Administration. Under this proposal, such a composition would be classified as a Schedule IV controlled substance.
Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Sponsors
- Brandon Wipf Republican lead
- Brian Mulder Republican lead
- Carl Perry Republican lead
- Eric Emery Democratic lead
- Erik Muckey Democratic lead
- Kadyn Wittman Democratic lead
- Mellissa Heermann Republican lead
- Nicole Uhre-Balk Democratic lead
- Scott Moore Republican lead
- Sydney Davis Republican lead
- Taylor Rehfeldt Republican lead
- Tim Goodwin Republican lead
- Tom Pischke Republican lead
Roll-call votes on this bill
| Question | Chamber | Result | Yea | Nay | Other | Date | Source |
|---|---|---|---|---|---|---|---|
| Do Pass | upper | pass | 21 | 12 | 2 | Mar 2, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Do Pass | upper | pass | 6 | 0 | 1 | Feb 25, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Do Pass | lower | pass | 58 | 7 | 5 | Feb 9, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |
| Do Pass | lower | pass | 13 | 0 | 0 | Feb 5, 2026 | Open States bulk CSV (bills/votes) CC0-1.0 |